LANGE LOUIS G sold 81.2% of their position (44.62K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Open‑market sale worth $1.36M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/12/2026ACC: 0001193125-26-104239
-44.62K
Net shares
Net seller
$1.36M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
44.62K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−44.17K
Price / share
$30.41
Trade value
$1.34M
% of position
80.3%
3/11/2026
54.98K→10.81K
Ordinary Shares
Direct
Shares
−446.00
Price / share
$31.23
Trade value
$13.93K
% of position
4.1%
3/11/2026
10.81K→10.36K
Total
Net shares
−44.62K
Net value
-$1.36M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/11/2026 | S · Sale | −44.17K | $30.41 | $1.34M | 80.3% | 54.98K | 10.81K |
| Ordinary Shares Direct | 3/11/2026 | S · Sale | −446.00 | $31.23 | $13.93K | 4.1% | 10.81K | 10.36K |
| Total | −44.62K | -$1.36M | ||||||
Derivative Transactions0
No derivative transactions reported